Home Clinical Trial Updates

Clinical Trial Updates

Clinical trial updates

$Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy$

Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy

Editorial Team - July 18, 2021

First patient Dosed with Trastuzumab Deruxtecan in DESTINY-Breast09 Trial

Valemetostat Promises Durable Tumor Response in Peripheral T-Cell Lymphoma and T-Cell Leukemia

Study Sheds Light on Treatment Options for Medulloblastoma

Single and Dual Immunotherapy Regimens May Offer Improved Overall Survival in Esophageal Cancer

Advancing Treatment Options with Immunotherapies in Non-Hodgkin’s Lymphoma

Editorial Team - June 5, 2021

General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019 ? ASCO/Max Gersh.

Improved OS with Bemarituzumab + Chemotherapy In FGFR2b+ Gastric and Gastroesophageal...

Editorial Team - June 4, 2021

A doctor examines mammogram snapshot of breast of patient on the monitors.

An Essential Protein may Lead to a New Treatment Option for...

Danielle Garcia - April 4, 2021

AbbVie booth at the 2019 annual meeting of the American Society of Clinical Oncology (ASCO) held June 1 - 4, 2019 in Chicago, Ill.

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team - October 16, 2020

ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III...

Editorial Team - September 18, 2020

ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm...

Danielle Garcia - September 18, 2020

ARAMIS Study Show Significantly Longer Overall Survival with Darolutamide in Non-metastatic...

Peter Hofland, Ph.D - September 14, 2020

Adjuvant Dabrafenib + Trametinib in Resected Stage III Melanoma w/BRAF Mutations:...

Editorial Team - September 11, 2020

Woman with lung cancer during medical visit

Tepotinib Shows Activity in Advanced NSCLC with a MET Exon 14...

Peter Hofland, Ph.D - September 10, 2020

Silverback Therapeutics Initiates Phase I clinical study of SBT6050

Editorial Team - September 5, 2020

12 3...24 Page 1 of 24

LATEST NEWS

Regular Blood Monitoring and a Tailored Treatment Approach in Mycosis Fungoides and Sézary Syndrome

Editorial Team - July 22, 2021

The National Cancer Act at 50: The Greatest Scientific Discovery Effort in History.

Peter Hofland, Ph.D - July 21, 2021

In States that Expanded Medicaid Cancer Mortality Rates Declined More Steeply

Editorial Team - July 21, 2021

Breakthrough Therapy Designation for Venetoclax + Azacitidine in Myelodysplastic Syndromes

Editorial Team - July 20, 2021

Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy

Editorial Team - July 18, 2021

Press Releases | Cancer

Local Breast Cancer Patients Experiencing Faster Recovery With PRMA’s... July 23, 2021
PRMA’s ERAS Protocol significantly decreases patient’s postoperative pain after breast reconstruction.(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/local_breast_cancer_patients_experiencing_faster_recovery_with_prmas_new_recovery_protocol/prweb18088964.htm
Mount Sinai Researchers Develop Novel Therapy That Could Be Effective... July 23, 2021
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer...(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/mount_sinai_researchers_develop_novel_therapy_that_could_be_effective_in_many_cancers/prweb18083920.htm
Deep Bio Announces Research Collaboration with a Major Cancer... July 22, 2021
Deep Bio renews Research Collaboration Agreement with Dana-Farber Cancer Institute(PRWeb July 22, 2021)Read the full story at https://www.prweb.com/releases/deep_bio_announces_research_collaboration_with_a_major_cancer_institute/prweb18081063.htm